Clinical Trial Update: Candesartan Versus Propranolol for Migraine Prevention [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial comparing candesartan to propranolol for migraine prevention has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Migraine Without Aura
• Migraine with Aura

Drugs mentioned

• Atacand (candesartan)
• Propranolol (propranolol)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Migraine Without Aura, Migraine With Aura | Phase 2, Phase 3 | Status: COMPLETED